SRL
UTHR icon

Scientech Research LLC’s United Therapeutics UTHR Stock Holding History

Scientech Research LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,855
Closed -$904K – 746
2025
Q4 		$904K Sell
1,855
-1,292
-41% -$602K 0.57% 23
2025
Q3 		$1.32M Sell
3,147
-3,004
-49% -$1.01M 0.46% 24
2025
Q2 		$1.77M Buy
+6,151
New +$1.84M 0.43% 30
2025
Q1 		– Sell
-1,451
Closed -$512K – 831
2024
Q4 		$512K Buy
1,451
+158
+12% +$58.1K 0.14% 286
2024
Q3 		$463K Sell
1,293
-1,122
-46% -$379K 0.09% 389
2024
Q2 		$769K Sell
2,415
-37
-2% -$9.79K 0.16% 234
2024
Q1 		$563K Sell
2,452
-3,921
-62% -$885K 0.3% 113
2023
Q4 		$1.4M Buy
+6,373
New +$1.47M 1.4% 5

Other funds holding UTHR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return